Skip to content
healthcare.dev

Paclitaxel

NDC 75007-041, Paclitaxel (aibumin-bound), injection, powder, lyophilized, for suspension, from Ningbo Shuangcheng Pharmaceutical Co., Ltd.

Product NDC
75007-041
Status
Listed
Labeler
Ningbo Shuangcheng Pharmaceutical Co., Ltd
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA216355
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/75007-041 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PACLITAXEL100 mg/100mg

Pharmacologic classes

Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]

Package NDCNDC-11Package

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4df3fda6-0b29-420e-ab91-81441ce914ed

Use it

Look up 75007-041 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/75007-041 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 75007-041. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.